IIT Kanpur licenses Bone Regeneration Technology to Conlis Global Inc.
This technology promotes bone regeneration by acting as a carrier for bone-active biomolecules, delivering them precisely to the implant site
image for illustrative purpose
Kanpur: The Indian Institute of Technology Kanpur (IIT-K) has entered into a Memorandum of Understanding (MOU) with Conlis Global Inc., a Canadian biotechnology company specializing in bringing research products to market. The agreement involves the licensing of a new bone regeneration technology developed by Prof. Ashok Kumar and his team from the Department of Biological Sciences & Bioengineering at IIT Kanpur.
The MOU signing took place at IIT Kanpur, with Prof. Tarun Gupta, Dean of Resources and Development, representing IIT Kanpur, and Dr. Sumrita Bhat, CEO of Conlis Global Inc., signing on behalf of the company. The event was attended by key figures including Prof. S. Ganesh, Director of IIT Kanpur, Prof. Ankush Sharma, Professor in charge of Start-up Incubation and Innovation Centre (SIIC) at IIT Kanpur, and Dr. Raman Koul, Chief Technology Officer at Conlis Global Inc.
Prof. S. Ganesh, Director of IIT Kanpur, emphasized the significance of this partnership, stating, "The licensing of this technology for bone healing and regeneration marks a notable milestone in our Institute's research and development efforts. This technology underscores the quality of research at IIT Kanpur, offering practical benefits that can impact people globally. We congratulate Prof. Ashok Kumar and his team for this achievement."
Dr Sumrita Bhat, CEO of Conlis Global Inc., expressed optimism about the potential of this technology, saying, "We are excited about our collaboration with IIT Kanpur to introduce this innovative solution to the market. It represents a significant advancement in the treatment of bone and joint disorders, with the potential to benefit patients worldwide."
Prof. Tarun Gupta, Dean of Resources and Development at IIT Kanpur, highlighted the MOU's importance in bridging the gap between research and commercialization. He stated, "This agreement with Conlis Global is a key milestone in our efforts to support researchers in bringing their innovations from the lab to the market. It inspires us to continue fostering research across various domains and assisting our talent in realizing their innovations."
The technology, titled "Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds for Bioactive Molecule Delivery in Musculoskeletal Regeneration," was developed by Prof. Ashok Kumar and his team. Prof. Kumar explained, "This technology promotes bone regeneration by acting as a carrier for bone-active biomolecules, delivering them precisely to the implant site. It offers a promising approach for reconstructing and repairing bone defects, addressing current market technologies' limitations."
The Nano Hydroxyapatite-based Porous Composite Scaffolds are biodegradable and possess osteoinductive and osteopromotive properties for bone regeneration. These scaffolds exhibit high biocompatibility, allowing for excellent cell-material interaction with osteoblast cells. They also demonstrate high mechanical strength and interaction within the polymer network and solvent. This technology can be used as filler in large bone defects, enhancing tissue formation, mineralization, and rapid healing, as well as serving as a bone substitute.
The primary aim of this invention is to overcome existing remedy drawbacks, such as infection and immune-related complications. Prof. Ashok Kumar highlighted its potential applications in delivering bone-active molecules, antibiotics, or other drugs for bone pathologies, irregular bone defect reconstruction, and dental applications.
